Fundraising FoxRose Therapeutics
Norristown, US · Founded 2022 · Delaware corporation
Find your way into Rose Therapeutics
Sign up to see every warm intro you have to Rose Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rose Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TL
Timothy LanglossPresident
IS
Ira SandersNamed on SEC filing
MW
Matthew WotizSecretary
Reported raises · per SEC filings
Form D private placements$650K disclosed across 1 round · 2022
▶$650KraisedSep 2022 · 5 investors · BiotechnologyRule 506(b)
▶$650KraisedSep 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew WotizExecutive Officer, Director
- Timothy LanglossExecutive Officer, Director
- Ira SandersDirector
- Offering amount
- $1M
- Amount sold
- $650K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Rose Therapeutics raised?
- Rose Therapeutics has disclosed $650K raised across 1 round.
- Where is Rose Therapeutics headquartered?
- Rose Therapeutics is headquartered in Norristown, US.